Donald Brooks
Impact in
-
- Vaccine Coverage and Hesitancy
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Cancer therapeutics and mechanisms 2
- Oncology 3
- Lung Cancer Research Studies 2
- Cancer Treatment and Pharmacology 2
- Co-authors
- Magali Soumillon (1 shared paper)Ulrich H. von Andrian (1 shared paper)Amy J. Wagers (1 shared paper)Robin Roberts (1 shared paper)Tarjei S. Mikkelsen (1 shared paper)Pamela J. Kling (1 shared paper)Raymond Taetle (1 shared paper)Paul R. Dragsten (1 shared paper)
- Journals
- Vaccine (2 papers)Vaccines (1 paper)Epidemiology and Infection (1 paper)The Journal of Organic Chemistry (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United StatesSwitzerlandRepublic of the Congo
In The Last Decade
Donald Brooks
14 papers receiving 190 citations
Peers
Comparison fields: 5 of 57
- Health 19
- Immunology 50
- Hematology 25
- Oncology 41
- Genetics 14
Countries citing papers authored by Donald Brooks
This map shows the geographic impact of Donald Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Brooks more than expected).
Fields of papers citing papers by Donald Brooks
This network shows the impact of papers produced by Donald Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Brooks. The network helps show where Donald Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Donald Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 63 | |
| 2 | 1996 | 35 | |
| 3 | Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients. | 2001 | 23 |
| 4 | 2024 | 17 | |
| 5 | Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors. | 2002 | 12 |
| 6 | 2024 | 10 | |
| 7 | 1995 | 9 | |
| 8 | 1984 | 7 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 4 | |
| 11 | 1990 | 4 | |
| 12 | 1999 | 3 | |
| 13 | 2025 | 2 | |
| 14 | A phase I study of etoposide phosphate plus paclitaxel. | 1996 | 2 |
| 15 | 2026 | 0 |
About Donald Brooks
Donald Brooks is a scholar working on Molecular Biology, Oncology, Epidemiology, Infectious Diseases and Health, having authored 15 papers that have together received 196 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (2 papers), Lung Cancer Research Studies (2 papers), COVID-19 epidemiological studies (2 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Treatment and Pharmacology (2 papers), Influenza Virus Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Health (19 citations), Immunology (50 citations), Hematology (25 citations), Oncology (41 citations) and Genetics (14 citations). Donald Brooks has collaborated with scholars based in United States, Switzerland and Republic of the Congo. Frequent co-authors include Magali Soumillon, Ulrich H. von Andrian, Amy J. Wagers, Robin Roberts, Tarjei S. Mikkelsen, Pamela J. Kling, Raymond Taetle, Paul R. Dragsten, Motohiko Kadoki and Deeksha Deep. Their work appears in journals such as Vaccine, Vaccines, Epidemiology and Infection, The Journal of Organic Chemistry and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.